Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.70 is 57% below its 5-year average of 18.00, near the low end of its 5-year range (7.70–43.05).
As of the fiscal period ended Tuesday, June 30, 2026. 26.25% below its 12-month average of 10.45.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.70.
CURRENT RATIO
7.70
CURRENT RATIO AVG TTM
10.45
CURRENT RATIO AVG 3Y
13.98
CURRENT RATIO AVG 5Y
18.00
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.25%
CURRENT VS 3Y AVG
-44.91%
CURRENT VS 5Y AVG
-57.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
+114.28%
vs the sector median at left
PMV Pharmaceuticals, Inc.
Market Cap
$90.13M
Current Ratio
7.70
TTM Avg
10.45
3Y Avg
13.98
5Y Avg
18.00
Market Cap
$90.42M
Current Ratio
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
Market Cap
$89.21M
Current Ratio
27.26
TTM Avg
12.68
3Y Avg
13.62
5Y Avg
17.71
Market Cap
$93.28M
Current Ratio
1.12
TTM Avg
0.73
3Y Avg
0.59
5Y Avg
0.59
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | $90.13M | 7.70 | 10.45 | 13.98 | 18.00 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $90.42M | 4.50 | 8.19 | 12.95 | 15.06 |
| Equillium, Inc. (EQ)vs › | $90.73M | 23.40 | 7.13 | 4.61 | 6.59 |
| ImmuCell Corporation (ICCC)vs › | $89.34M | 4.75 | 3.83 | 3.74 | 4.48 |
| Rallybio Corporation (RLYB)vs › | $89.21M | 27.26 | 12.68 | 13.62 | 17.71 |
| electroCore, Inc. (ECOR)vs › | $91.51M | 1.21 | 1.40 | 1.89 | 3.11 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.28M | 1.12 | 0.73 | 0.59 | 0.59 |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 1.02 | 1.16 | 1.22 | 1.27 |
| Biomea Fusion, Inc. (BMEA)vs › | $93.63M | 3.47 | 4.19 | 5.60 | 16.48 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.42M | 1.98 | 0.65 | 1.44 | 2.62 |
Current Ratio
7.70
Quick Ratio
7.70
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.70 |
| 2026-03-31 | 11.14 |
| 2025-12-31 | 10.09 |
| 2025-09-30 | 10.76 |
| 2025-06-30 | 12.52 |
| 2025-03-31 | 16.75 |
| 2024-12-31 | 12.22 |
| 2024-09-30 | 13.98 |
| 2024-06-30 | 19.22 |
| 2024-03-31 | 16.79 |
| 2023-12-31 | 14.78 |
| 2023-09-30 | 19.16 |
| 2023-06-30 | 16.63 |
| 2023-03-31 | 22.03 |
| 2022-12-31 | 22.80 |
| 2022-09-30 | 22.75 |
| 2022-06-30 | 24.76 |
| 2022-03-31 | 24.65 |
| 2021-12-31 | 24.66 |
| 2021-09-30 | 36.62 |
| 2021-06-30 | 43.05 |
| 2021-03-31 | 57.79 |
| 2020-12-31 | 56.90 |
| 2020-09-30 | 68.24 |
| 2020-06-30 | 17.07 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 22.57 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
